Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
Zero Ads
@zeroadsapp· 4 followers
Launched
16d ago
2026-11-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@zeroadsapp
  • Launched on Product HuntLaunch

    Fewer ads on iPhone and Android

    Nov 3 · 16d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Ads & Trackers
Unknown
Malware Only
Unknown
Security
Unknown
Family
Unknown
Cloudflare Filtered
Unknown
Quad9 Filtered
Unknown

Trial: None · Observed 2026-11-08 · Source page

Pages & changes

Tracked since 2026-11-03

Key pages

Weekly snapshots
Home
zeroads.app/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Zero Ads cost?
Ads & Trackers: Unknown; Malware Only: Unknown; Security: Unknown; Family: Unknown; Cloudflare Filtered: Unknown; Quad9 Filtered: Unknown. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Zero Ads get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Zero Ads and what platforms does it support?
Zero Ads is catalogued under VPN & Privacy Protection: Your internet. With fewer ads. Supported platforms: Mobile App.

Related products in this category

Security & Privacy / VPN & Privacy Protection

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.